The United States Active Pharmaceutical Ingredient Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Active Pharmaceutical Ingredient industry.
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Active Pharmaceutical Ingredient market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.
Interested in report: Please follow the below the links to meet your requirements;http://www.researchmoz.us/united-states-active-pharmaceutical-ingredient-industry-2016-market-research-report-report.html
Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.
The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Active Pharmaceutical Ingredient industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.
With 199 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Table of Contents
1. Industry Overview 1
1.1Definition of Active Pharmaceutical Ingredient 1
1.2 Classification of Active Pharmaceutical Ingredient 2
1.2.1 Synthetic API 4
1.2.2 Biotech API 5
1.2.3 Other 5
1.3 Applications of Active Pharmaceutical Ingredient 6
1.4 Industry Chain Structure of Active Pharmaceutical Ingredient 8
1.5 Industry Overview of Active Pharmaceutical Ingredient 8
1.6 Industry Policy Analysis of Active Pharmaceutical Ingredient 9
1.6.1 Guidance for Industry, Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical Ingredients 9
1.6.2 Drug Supply Chain Security Act (DSCSA) - Title II of the Drug Quality and Security Act of 2013 10
1.7 Industry News Analysis of Active Pharmaceutical Ingredient 12
2. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient 14
2.1 Bill of Materials (BOM) of Active Pharmaceutical Ingredient 14
2.1.1 M-Cresol 15
2.1.2 Corn Starch 15
2.2 BOM Price Analysis of Active Pharmaceutical Ingredient 18
2.3 Labor Cost Analysis of Active Pharmaceutical Ingredient 19
2.4 Other Cost Analysis of Active Pharmaceutical Ingredient 20
2.5 Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredient 23
2.6 Manufacturing Process Analysis of Active Pharmaceutical Ingredient 24
2.7 United States Disposable Personal Income and Regional Macroeconomic 24
For more info, get a Sample PDF with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=658765
3. Technical Data and Manufacturing Plants Analysis 27
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2015 27
3.2 Manufacturing Plants Distribution of United States Key Active Pharmaceutical Ingredient Manufacturers in 2015 27
3.3 R&D Status of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015 28
3.4 Raw Materials Sources Analysis of United States Active Pharmaceutical Ingredient Key Manufacturers in 2015 28
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare, +1–518–621–2074
USA-Canada Toll Free: 866–997–4948
Email: sales@researchmoz.us
WebSite:http://www.researchmoz.us/
0 comments:
Post a Comment